BioSpace News Archive

Business

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors

October 21, 2024
·
5 min read
Business

Halia Therapeutics to Attend Global Health Exhibition 2024

October 21, 2024
·
3 min read
News

Cerevance Announces Publication of Positive Phase 2 Results of Solengepras for the Treatment of Parkinson’s Disease in eClinicalMedicine

October 21, 2024
·
5 min read
News

Moonwalk Biosciences to Present New Epigenetic Data at ObesityWeek® 2024 and The Liver Meeting® 2024

October 21, 2024
·
3 min read
News

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

October 21, 2024
·
7 min read
News

FDA Approves NGS-Based Companion Diagnostic for First Targeted Therapy for Patients with Grade 2 IDH-Mutant Glioma

October 21, 2024
·
4 min read
Business

Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details

October 21, 2024
·
1 min read
Press Releases

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

October 21, 2024
·
6 min read
Business

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

October 21, 2024
·
3 min read
News

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting

October 21, 2024
·
1 min read